Search Result "MplW515L/K mutation"
Stem Cell Defects in Philadelphia Chromosome Negative Chronic Myeloproliferative Disorders: A Phenotypic and Molecular Puzzle?
Journal: Current Stem Cell Research & Therapy
Volume: 2 Issue: 3 Year: 2007 Page: 253-263
Author(s): Oliver Bock, Kais Hussein, Hans Kreipe
JAK2 Inhibitors for Myelofibrosis: Why are They Effective in Patients with and Without JAK2V617F Mutation?
Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 12 Issue: 9 Year: 2012 Page: 1098-1109
Author(s): Fabio P. S. Santos,Srdan Verstovsek
The Use of Structural Biology in Janus Kinase Targeted Drug Discovery
Journal: Current Drug Targets
Volume: 12 Issue: 4 Year: 2011 Page: 546-555
Author(s): Nilda L. Alicea-Velazquez, Titus J. Boggon
JAK2 as a Molecular Marker in Myeloproliferative Diseases
Journal: Cardiovascular & Hematological Agents in Medicinal Chemistry
Volume: 5 Issue: 3 Year: 2007 Page: 198-203
Author(s): R. Mata, D. Subira, A. Garcia-Raso, P. Llamas
JAK Inhibitors: Pharmacology and Clinical Activity in Chronic Myeloprolipherative Neoplasms
Journal: Current Medicinal Chemistry
Volume: 20 Issue: 9 Year: 2013 Page: 1147-1161
Author(s): J. Trelinski,T. Robak
Insights into the Structural Features Essential for JAK2 Inhibition and Selectivity
Journal: Current Medicinal Chemistry
Volume: 23 Issue: 13 Year: 2016 Page: 1331-1355
Author(s): Chao Zhao,Daulat Bikram Khadka,Won-Jea Cho
Current and Emerging Therapies in Primary Myelofibrosis
Journal: Cardiovascular & Hematological Disorders-Drug Targets
Volume: 12 Issue: 1 Year: 2012 Page: 6-20
Author(s): Sabarish Ayyappan,Murali Janakiram,Radha Raghupathy
Epigenetic Modifications: New Therapeutic Targets in Primary Myelofibrosis
Journal: Current Stem Cell Research & Therapy
Volume: 4 Issue: 4 Year: 2009 Page: 281-286
Author(s): Kirugaval Hemavathy, Jen C. Wang
Janus Kinase (JAK) Inhibitors in Rheumatoid Arthritis
Journal: Current Rheumatology Reviews
Volume: 7 Issue: 4 Year: 2011 Page: 306-312
Author(s): Kunihiro Yamaoka, Yoshiya Tanaka
Biology and Clinical Management of Myeloproliferative Neoplasms and Development of the JAK Inhibitor Ruxolitinib
Journal: Current Medicinal Chemistry
Volume: 19 Issue: 2 Year: 2012 Page: 4399-4413
Author(s): J. Mascarenhas, T. I. Mughal, S. Verstovsek